| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.1056/NEJME0906886 |
| P698 | PubMed publication ID | 19717843 |
| P2093 | author name string | Brian F Gage | |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1200-1202 | |
| P577 | publication date | 2009-08-30 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Can we rely on RE-LY? | |
| P478 | volume | 361 |
| Q50501003 | A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation |
| Q35142419 | Antithrombotic medication for cardioembolic stroke prevention |
| Q34362901 | Antithrombotic therapy in cardiac embolism |
| Q35187005 | Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis |
| Q28244905 | Dabigatran etexilate: A novel oral direct thrombin inhibitor |
| Q44783204 | Dabigatran: a new therapeutic alternative in the prevention of stroke |
| Q37990337 | Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use. |
| Q56003308 | Direct Thrombin Inhibitors |
| Q88302794 | Early Outcome after Intracranial Hemorrhage Related to Non-Vitamin K Oral Anticoagulants |
| Q38685055 | First Reported Case of Hemopericardium Related to Dabigatran Use Reversed by New Antidote Idarucizumab. |
| Q33888320 | New options with dabigatran etexilate in anticoagulant therapy |
| Q35739671 | New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders |
| Q36443814 | Novel anticoagulants in atrial fibrillation stroke prevention |
| Q37197199 | Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis |
| Q37810102 | Novel oral anticoagulants. Part II: direct thrombin inhibitors |
| Q37900185 | Oral anticoagulant-associated intracerebral hemorrhage |
| Q37802084 | Recent advances in oral anticoagulation for atrial fibrillation |
| Q36916381 | Recent trends in cost-related medication nonadherence among stroke survivors in the United States |
| Q41138334 | Synthesis and Biological Evaluation of Some New 2,5-Substituted 1-Ethyl-1H-benzoimidazole Fluorinated Derivatives as Direct Thrombin Inhibitors |
| Q37843744 | Transforming oral anticoagulation by combining international normalized ratio (INR) self testing and online automated management |
| Q42818589 | Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems |
| Q85334978 | [Scope of the latest RE-LY substudies: clinical implications] |
Search more.